Bangalore

Apotex Research Pvt. Ltd. is a wholly owned subsidiary of Apotex Inc. Canada which is a number one generic pharma co. in Canada. The position is for Bangalore location which has an R&D Centre, Manufacturing and a Bioequivalence Centre.

Inspired and moved to share  below the essence of a true story which has unfolded in our own country in the recent past and in our own midst:

1. Which of the following trademarked sustained release systems are based on encapsulated drug particles that will dissolve at various rates ?  
I.   Sequels
II.   Spansules
III.  Extentabs.
Of these
A)  I only
B)  III Only
C) I and II
D) I, II, and III

Headquartered in Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional CRO. With the increasing pace of globalisation in drug development, Novotech’s expertise in the vibrant and fast growing Asian region has been instrumental in the success of hundreds of phase I-IV clinical trials from Australia to India. Our highly experienced 140 strong staff based in 8 countries and 15 locations across the region provide access to patients from a population base of over 1.5 billion people. This breadth of reach, supported by the most sophisticated market data commercially available, enables us to conduct extremely thorough feasibility assessments for almost any study.

Post : Sales Analyst

Candidates after submitting their applications through On-Line shall send photocopies of their all academic/required documents regarding their claims along with print out of On-Line application form within 21 days from the last date of submitting the applications (date 03rd October, 2016 till 5.00 O' Clock) on the working day through registered/Speed Post or Personally in the office of the Commission.

Caplin Point Laboratories Ltd generate over US$50 million in revenue annually with a healthy bottom line. We have recently been selected by Forbes Asia magazine as one of the Top 200 best performing companies in Asia, for the second time in a row. Caplin is the only Pharma company in India to be selected in both 2014 and 2015. We have been manufacturing, exporting and distributing our products to Latin America and Africa for the last 16 years and we're already in the Top 5 exporters from India to Latin America over the last few years. We are currently holding over 2000 product licenses in these regions with another 490 in the pipeline. Our latest Injectable facility in Gummidipoondi, built with a budget of HOcr has been funded entirely from internal accruals. The injectable factory has been approved by European Union and Brazil, with US FDA inspection likely to take place by 2016 last quarter.